SCHEMBL19079727

SCHEMBL19079727

CC(C1CC1)n1c(SCC(=O)Nc2nccs2)nc2sccc2c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ ALOX15 P16050 3/20 0.49
▸ PKM P14618 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ TSHR P16473 2/20 0.49
▸ POLB P06746 2/20 0.48
▸ PRNP P04156 1/20 0.48
▸ LMNA P02545 1/20 0.47
▸ PIK3C2A O00443 5/20 0.47
▸ HTT P42858 2/20 0.46
▸ SLC22A12 Q96S37 1/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079681 0.87 POLB (0.50) CYP1A2CYP3A4MAPTCYP2C9CYP2C19
SCHEMBL19079722 0.85 POLB (0.47) POLBLMNASLC22A12
SCHEMBL19079721 0.84 POLB (0.45) MAPTPOLBLMNAHTTSLC22A12
SCHEMBL19079731 0.84 POLB (0.53) MAPTALDH1A1POLBLMNASLC22A12
SCHEMBL19079772 0.84 KMT2A (0.47) MAPTALDH1A1POLBHTTSLC22A12
SCHEMBL19079683 0.83 APOBEC3A (0.52) MAPTALDH1A1POLBLMNASLC22A12
SCHEMBL19079769 0.80 PDE4D (0.68) MAPTCYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL21586354 0.69 PIK3C2A (0.71) CYP1A2CYP3A4MAPTCYP2C9CYP2C19
SCHEMBL21586356 0.69 PIK3C2A (0.71) CYP1A2CYP3A4MAPTCYP2C9CYP2C19
SCHEMBL5449146 0.65 MEN1 (0.79) CYP1A2MAPTCYP2C9CYP2C19PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase VANDERBILT UNIVERSITY (US) 2019-06-25 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase PDE4A, PDE4B, PDE7A CYP1A2 3725/4885CYP3A4 3206/4885MAPT 4761/4885
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase PDE4A, PDE4B, PDE7A CYP1A2 3725/4885CYP3A4 3206/4885MAPT 4761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback